Status:
COMPLETED
Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome
Lead Sponsor:
University Hospital, Lille
Conditions:
Lynch Syndrome
Eligibility:
FEMALE
30+ years
Brief Summary
Lynch Syndrome increases Endometrial Cancer Occurrence in women due to failure in MisMatch Repair System. Lifetime Cumulative risk of developing endometrial Cancer is approximatively 40% in women with...
Eligibility Criteria
Inclusion
- Lynch Syndrome Diagnosis at University Hospital
- Alive at study time
- Age over 30 at endometrial cancer or Lynch Syndrome Diagnosis
- Case group :
- \- No cancer before endometrial cancer diagnosis
- Control group :
- No endometrial cancer developped
- Free cancer women at Lynch Syndrome diagnosis
Exclusion
- Refusing to participate
- Poor understanding of the French language
- Other cancer diagnosed before endometrial cancer
- Hysterectomy before lynch diagnosis for free cancer women
Key Trial Info
Start Date :
August 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 20 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04452266
Start Date
August 14 2020
End Date
October 20 2020
Last Update
March 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Jeanne de Flandres
Lille, France, 59000